Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Top Cited Papers
- 1 September 2007
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 370 (9591) , 949-956
- https://doi.org/10.1016/s0140-6736(07)61445-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The challenges of new drugs benefits and risks analysis: Lessons from the ximelagatran FDA Cardiovascular Advisory CommitteeContemporary Clinical Trials, 2006
- Oral Anticoagulants in DevelopmentDrugs, 2006
- Emerging anticoagulants for the treatment of venous thromboembolismThrombosis and Haemostasis, 2006
- Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolismEuropean Heart Journal, 2005
- A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trialJournal of Thrombosis and Haemostasis, 2005
- The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyJournal of Thrombosis and Haemostasis, 2003
- Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip ArthroplastyArchives of internal medicine (1960), 2003
- Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trialsActa Radiologica, 1997
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972